C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 0.8500
-0.0050 (-0.58%)
Sep 2, 2026, 3:20 PM HKT
C-MER Medical Holdings Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 543.63 | 347.87 | 423.08 | 512.76 | 644.7 | 386.66 |
Short-Term Investments | 81.48 | 107.09 | 28.98 | 32.91 | 31.33 | - |
Trading Asset Securities | 6.7 | 11 | 15.19 | 11.75 | 22.48 | 55.7 |
Cash & Short-Term Investments | 631.81 | 465.96 | 467.25 | 557.42 | 698.51 | 442.36 |
Cash Growth | 45.01% | -0.27% | -16.18% | -20.20% | 57.90% | -20.14% |
Accounts Receivable | 58.32 | 65.69 | 57.76 | 53.37 | 47.13 | 17.98 |
Other Receivables | 2.4 | 19.25 | 15.09 | 13.86 | 12.94 | 16.69 |
Receivables | 60.72 | 84.94 | 72.86 | 67.23 | 60.07 | 34.67 |
Inventory | 55.38 | 54.14 | 51.94 | 41.97 | 55.62 | 34.46 |
Prepaid Expenses | - | 27.75 | 16.79 | 17.62 | 11.89 | 14.76 |
Other Current Assets | - | 38.6 | 31.64 | 35.9 | 30.47 | 220.14 |
Total Current Assets | 747.91 | 671.39 | 640.48 | 720.14 | 856.56 | 746.39 |
Property, Plant & Equipment | 1,024 | 994.82 | 949.2 | 992.82 | 1,058 | 901.29 |
Long-Term Investments | 140.71 | 140.71 | 247.29 | 176.33 | 116.13 | 77.39 |
Goodwill | - | 487.72 | 440.11 | 530.43 | 540.68 | 194.97 |
Other Intangible Assets | 779.62 | 273.13 | 259.8 | 271.76 | 280.71 | 8.99 |
Long-Term Deferred Tax Assets | 4.33 | 2.87 | 4.71 | 6.82 | 6.94 | 10.97 |
Other Long-Term Assets | 166.69 | 161.98 | 178.57 | 50.35 | 43.03 | 15.88 |
Total Assets | 2,864 | 2,733 | 2,720 | 2,749 | 2,902 | 1,956 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 58.69 | 50.36 | 55.81 | 54.92 | 45.31 | 39.87 |
Accrued Expenses | 163.7 | 139.66 | 131.49 | 125.81 | 107.32 | 64.37 |
Short-Term Debt | 45.97 | 44.35 | 29.16 | 1.73 | 34.26 | 179.41 |
Current Portion of Long-Term Debt | 7.65 | 7.44 | 7.5 | 7.61 | - | - |
Current Portion of Leases | 119.05 | 119.44 | 102.44 | 107.2 | 115.08 | 86.07 |
Current Income Taxes Payable | 23.58 | 21.28 | 6.51 | 23.97 | 18.85 | 8.54 |
Current Unearned Revenue | 66.16 | 64.06 | 57.54 | 54.19 | 39.49 | 10.73 |
Other Current Liabilities | 49.17 | 21.8 | 19.57 | 13.9 | 164.5 | 19.27 |
Total Current Liabilities | 533.97 | 468.39 | 410.02 | 389.33 | 524.8 | 408.25 |
Long-Term Debt | - | - | 12.42 | 13.8 | 21.22 | 7.6 |
Long-Term Leases | 260.93 | 255.55 | 286.27 | 232.66 | 281.94 | 198.62 |
Long-Term Deferred Tax Liabilities | 69.27 | 66.79 | 64.15 | 66.22 | 72.53 | 0.52 |
Other Long-Term Liabilities | 4.41 | 5.28 | 57.38 | 53.34 | 2.97 | 3.66 |
Total Liabilities | 868.58 | 796.01 | 830.24 | 755.35 | 903.45 | 618.63 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 123.23 | 123.23 | 125.56 | 125.56 | 126.66 | 115.03 |
Additional Paid-In Capital | - | 1,651 | 1,693 | 1,693 | 1,733 | 1,087 |
Retained Earnings | - | 43.75 | -32.55 | 103.67 | 41.68 | 63.55 |
Treasury Stock | - | -114.72 | -105.73 | -46.59 | -29.93 | - |
Comprehensive Income & Other | 1,712 | 71.69 | 72.8 | -29.43 | -5.47 | 65.92 |
Total Common Equity | 1,835 | 1,775 | 1,753 | 1,846 | 1,866 | 1,331 |
Minority Interest | 160.34 | 161.67 | 137.23 | 147.47 | 132.18 | 6.01 |
Shareholders' Equity | 1,995 | 1,937 | 1,890 | 1,993 | 1,998 | 1,337 |
Total Liabilities & Equity | 2,864 | 2,733 | 2,720 | 2,749 | 2,902 | 1,956 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 433.61 | 426.78 | 437.79 | 362.99 | 452.49 | 471.69 |
Net Cash (Debt) | 198.2 | 39.18 | 29.46 | 194.43 | 246.03 | -29.33 |
Net Cash Growth | 1475.15% | 33.01% | -84.85% | -20.97% | - | - |
Net Cash Per Share | 0.17 | 0.03 | 0.02 | 0.15 | 0.20 | -0.03 |
Filing Date Shares Outstanding | 1,189 | 1,190 | 1,221 | 1,244 | 1,259 | 1,236 |
Total Common Shares Outstanding | 1,189 | 1,190 | 1,221 | 1,244 | 1,259 | 1,150 |
Working Capital | 213.94 | 203 | 230.45 | 330.81 | 331.76 | 338.14 |
Book Value Per Share | 1.54 | 1.49 | 1.44 | 1.48 | 1.48 | 1.16 |
Tangible Book Value | 1,055 | 1,014 | 1,053 | 1,044 | 1,045 | 1,127 |
Tangible Book Value Per Share | 0.89 | 0.85 | 0.86 | 0.84 | 0.83 | 0.98 |
Buildings | - | 68.92 | 83.18 | 86.08 | 88.44 | 19.75 |
Machinery | - | 524.13 | 462.14 | 475.16 | 466.86 | 337.72 |
Construction In Progress | - | 164.23 | 147.94 | 74.35 | 26.36 | 7.9 |
Leasehold Improvements | - | 278.97 | 251.31 | 249.1 | 235.85 | 169 |